Expression of P-Glycoprotein in Hepatocellular Carcinoma
Open Access
- 1 March 2000
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 113 (3) , 355-363
- https://doi.org/10.1309/ac1m-4ty4-u0tn-en7t
Abstract
To characterize the P-glycoprotein (Pgp) expression in human hepatocellular carcinoma (HCC), we studied 101 cases of HCC treated with surgical resectKeywords
This publication has 25 references indexed in Scilit:
- Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis.Journal of Clinical Pathology, 1996
- Prognostic significance of pathologic features of hepatocellular carcinoma a multivariate analysis of 278 patientsCancer, 1995
- Interaction of tamoxifen with the multidrug resistance P-glycoproteinBritish Journal of Cancer, 1995
- A phase I trial of intrahepatic Verapamil and doxorubicin. Regional therapy to overcome multidrug resistanceCancer, 1994
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product p-glycoprotein in primary liver carcinomaCancer, 1994
- P‐glycoprotein expression in hepatocellular carcinomaJournal of Surgical Oncology, 1993
- Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53Science, 1992
- Mutational hot spot in the p53 gene in human hepatocellular carcinomasNature, 1991
- Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsiesCancer, 1954